5-Hydroxytryptamine(1A) receptor-mediated increases in receptor expression and activation of nuclear factor-κB in transfected Chinese hamster ovary cells

Molecular Pharmacology

Volumn 52, Issue 2, 1997, Pages 221-226

  Cowen, Daniel S ^a,b   Molinoff, Perry B ^a,c   Manning, David R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLOHEXIMIDE; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; PINDOLOL; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SPIPERONE; RECOMBINANT PROTEIN; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR UPREGULATION; ANIMAL; CYTOMEGALOVIRUS; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; METABOLISM; PHYSIOLOGY; PROMOTER REGION; UPREGULATION;

ANIMALS; CHO CELLS; CRICETINAE; CYTOMEGALOVIRUS; GENETIC VECTORS; HUMANS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECOMBINANT PROTEINS; TRANSFECTION; UP-REGULATION;

EID: 0030611419     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.2.221     Document Type: Article

References (40)

1. 1B receptor in opossum kidney cells after exposure to agonists. Mol. Pharmacol. 42:464-470 (1992).
2. 2 receptors in P11 cells. Mol. Pharmacol. 43:726-733 (1993).
3. 1C receptor density and mRNA levels in choroid plexus epithelium after treatment with mianserin and (-)-1(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol. Pharmacol. 44:725-730 (1993).
4. Hausdorff, W. P., M. G. Caron, and R. J. Lefkowitz. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 4:2881-2889 (1990).
5. Kobilka, B. Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 15:87-114 (1992).
6. 2 receptors in a novel cell line (SUP1). Mol. Pharmacol. 39:531-539 (1991).
7. 2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 271:1574-1582 (1994).
8. 2 receptors on cultured cells. J. Neurochem. 65:569-577 (1995).
9. 2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45:878-889 (1994).
10. 2A receptors in heterologous expression systems. J. Neurochem. 63:1255-1260 (1994).
11. 3-adrenergic receptor expression via multiple cAMP response elements. Proc. Natl. Acad. Sci. USA 89:4490-4494 (1992).
12. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6:3474-82 (1986).
13. 1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144 (1991).
14. Blier, P., C. de Montigny, and Y. Chaput. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J. Clin. Psychiatry 51:14-20 (1990).
15. 1A receptor. J. Biol. Chem. 266:14747-14753 (1996).
16. 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem. 271:2297-22300 (1996).
17. 3 dopamine receptors. Neuropsychopharmacology 12:335-349 (1995).
18. Stein, B., H. F. Rahmsdorf, A. Steffen, M. Liftin, and P. Herlich. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodefficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9:5169-5181 (1989).
19. 1A ligand. J. Med. Chem. 37:1406-1407 (1994).
20. 1A receptor antagonist: p-MPPI. Life Sci. 55:1459-1462 (1994).
21. De Vivo, M., and S. Maayani. Characterization of 5-hydroxytryptamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238:248-255 (1986).
22. 1A receptor. J. Biol. Chem. 264:14848-14852 (1989).
23. 1A receptor in Sf9 cells. J. Biol. Chem. 270:18691-18699 (1995).
24. 1A receptor via a G protein βγ-subunit-initiated pathway. Biochemistry 35:13716-13722 (1996).
25. Brown, K., S. Park, T. Kanno, G. Franzosa, and U. Siebenlist. Mutual regulation of the transcriptional activator NFκB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90:2532-2536 (1993).
26. Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. TNF activates NFκ-B by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 71:765-776 (1992).
27. Sambucetti, L., J. Cherrington, G. Wilkinson, and E. Mocarski. NFκ-B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258 (1989).
28. Prosch, S., K. Staak, J. Stein, C. Liebenthal, T. Stamminger, H. Volk, and D. Kruger. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFα is mediated by NFκ-B. Virology 208: 197-206 (1995).
29. 1 receptors in HeLa cell stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools. J. Biol Chem. 265:372 (1990).
30. 1A receptors. J. Biol. Chem. 268:1098-1006 (1994).
31. 1A receptor ligand. J. Med. Chem. 36:3161-3165 (1993).
32. Beg, A. A., and A. S. Baldwin. The IκB proteins: multifunctional regulators of Rel/NFκ-B transcription factors. Genes Dev. 7:2064-2070 (1993).
33. Gilmore, T. D. NFκ-B, KBF1, dorsal, and related matters. Cell 62:841-843 (1990).
34. Finco, T. S., and A. S. Baldwin, A. S. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires raf-1. J. Biol. Chem. 268:17676-17679 (1993).
35. Hirano, M., S. Osada, T. Aoki, S. Hirai, M. Hosaka, J. Inoue, and S. Ohno. MEK kinase is involved in tumor necrosis factor α-induced NFκ-B activation and degradation of IκBα. J. Biol. Chem. 271:3234-13238 (1996).
36. Cai, H., P. Erhardt, J. Szeberenyl, M. T. Diaz-Meco, T. Johansen, J. Moscat, and G. M. Cooper. Hydrolysis of phosphatidylcholine is stimulated by ras proteins during mitogenic signal transduction. Mol. Cell. Biol. 12:5329-5335 (1992).
37. Kravchenko, V. V., Z. Pan, J. Han, J. Herbert, R. J. Ulevitch, and R. D. Ye. Platelet-activating factor induces NFκ-B activation through a G protein-coupled pathway. J. Biol. Chem. 270:14928-14934 (1995).
38. Hunninghake, G. W., M. M. Monick, B. B. Liu, and M. F. Stinski. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63:3026-3033 (1989).
39. Shelborn, S. L., S. K. Kothari, J. G. Sissons, and J. H. Sinclair. Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res. 17:9165-9171 (1989).
40. Niller, H. H., and L. Hennighausen. Formation of several specific nucleo-protein complexes on the human cytomegalovirus immediate early enhancer. Nucleic Acids Res. 19:3715-3721 (1991).